|
Volumn 59, Issue 11, 2001, Pages 2239-2244
|
Asterriquinone derivatives as candidates for new orally available anti-diabetics
|
Author keywords
[No Author keywords available]
|
Indexed keywords
2,5 DIHYDROXY 3 (1 METHYLINDOL 3 YL) 6 PHENYL 1,4 BENZOQUINONE;
2,5-DIHYDROXY-3-(1-METHYLINDOL-3-YL)-6-PHENYL-1,4-BENZOQUINONE;
ANTIDIABETIC AGENT;
ASTERRIQUINONE;
BENZOQUINONE DERIVATIVE;
INDOLE DERIVATIVE;
NORASTERRIQUINONE B1;
ANIMAL;
DIABETES MELLITUS;
HUMAN;
INSULIN RESISTANCE;
ORAL DRUG ADMINISTRATION;
PATHOPHYSIOLOGY;
REVIEW;
STRUCTURE ACTIVITY RELATION;
ADMINISTRATION, ORAL;
ANIMALS;
BENZOQUINONES;
DIABETES MELLITUS;
HUMANS;
HYPOGLYCEMIC AGENTS;
INDOLEQUINONES;
INDOLES;
INSULIN RESISTANCE;
STRUCTURE-ACTIVITY RELATIONSHIP;
|
EID: 0035512713
PISSN: 00471852
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
Times cited : (1)
|
References (7)
|